Status:
COMPLETED
Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to compare patient ratings of how severe their own symptoms may be, with their caregivers' ratings of how severe they think the patients' symptoms may be. This will be compar...
Detailed Description
Study Visit: If you and your caregiver agree to take part in this study, you will both complete 2 questionnaires. You will be in separate rooms when you complete the questionnaires. The first questi...
Eligibility Criteria
Inclusion
- Imaging consistent with a primary brain tumor or prior pathologic diagnosis of primary brain tumor
- Referred for neurocognitive function testing as part of the plan of care
- Age \> or = 18 years of age
- Ability to speak, read, and write the English language
- Caregiver Attribute: Identified by the patient as being primarily involved in the patients' care in the home setting (biologic, legal, or functional relationship)
- Caregiver Attribute: Able to speak, read, and write the English language
- Both patient and caregiver have to agree to participate
- The caregiver needs to be present at the time the patient is recruited
Exclusion
- Patients less than 18 years of age will be excluded from this study.
- Patients will be excluded from the study if they are unable to complete the self-report questionnaire or participate in neurocognitive testing.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00748774
Start Date
May 1 2008
End Date
September 1 2014
Last Update
January 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030